Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
905.4000 -4.50 (-0.49%)
NSE Nov 21, 2025 09:50 AM
Volume: 18,462
 

logo
Alivus Life Sciences Ltd.
29 Apr 2023
905.40
-0.49%
buy
by BOB Capital Markets Ltd.
Target: 600
BOB Capital Markets Ltd.
Q4 revenue of Rs 6.2bn (+21% YoY) beat our estimate by 14% driven by recovery in CDMO and growth in API
 
Alivus Life Sciences Ltd. is trading below all available SMAs
More from Alivus Life Sciences Ltd.
Recommended
Market opens lower, TCS forms Rs 18,000 cr JV
Trendlyne Marketwatch | 21 Nov 2025, 09:42AM
Inflation Is near zero. So why Is the RBI not cutting rates?
The Baseline | 20 Nov 2025, 01:04PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021